Esperion Therapeutics Inc [ESPR] Revenue clocked in at $295.45 million, down -19.40% YTD: What’s Next?
Esperion Therapeutics Inc [NASDAQ: ESPR] traded at a high on Thursday, posting a 12.09 gain after which it closed the day’ session at $2.41. The results of the trading session contributed to over 5584127 shares changing hands. Over the past one week, the price volatility